Sarat Chander

Selection of motion management in liver stereotactic body radiotherapy and its impact on treatment time.

Nicholas Hardcastle, Mathieu Gaudreault, Adam U Yeo, Elena Ungureanu, Cathy Markham, Rebecca Barnes, Sarat Chander, Julie Chu

Journal article  |  2023  |  Phys Imaging Radiat Oncol

BACKGROUND AND PURPOSE: Reduction of respiratory tumour motion is important in liver stereotactic body radiation therapy (SBRT) to..

Impact of Medical Operability and Total Metastatic Ablation on Outcomes After SABR for Oligometastases

Shankar Siva, Gavin Jones, Mathias Bressel, Mark Shaw, Sarat Chander, Julie Chu, Nikki Plumridge, Keelan Byrne, Gargi Kothari, Nicholas Hardcastle, Mathieu Gaudreault, Tomas Kron, Greg Wheeler, Michael MacManus, Gerard G Hanna, David L Ball, Steven David

Journal article  |  2022  |  INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

PURPOSE: Medical operability is prognostic for survival after SABR in primary malignancies. This study investigated the prognostic..

Impact of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in the Management of Oligometastatic Renal Cell Carcinoma

Cristian Udovicich, Jason Callahan, Mathias Bressel, Wee Loon Ong, Marlon Perera, Ben Tran, Arun Azad, Shankar Haran, Daniel Moon, Sarat Chander, Mark Shaw, Renu Eapen, Jeremy Goad, Nathan Lawrentschuk, Declan G Murphy, Michael Hofman, Shankar Siva

Journal article  |  2022  |  EUROPEAN UROLOGY OPEN SCIENCE

BACKGROUND: Prostate-specific membrane antigen (PSMA) is overexpressed in the neovasculature of renal cell carcinoma (RCC). Howeve..

MO-0471 Motion management in liver SBRT and its impact on treatment time

N Hardcastle, M Gaudreault, A Yeo, E Ungureanu, R Barnes, C Markham, S Chander, J Chu

Journal article  |  2022  |  Radiotherapy and Oncology

Impact of operability and total metastatic ablation on outcomes after SABR for oligometastases

S Siva, M Bressel, P Sogono, M Shaw, S Chander, J Chu, N Plumridge, K Byrne, G Kothari, N Bucknell, N Hardcastle, T Kron, G Wheeler, M MacManus, GG Hanna, DL Ball, S David

Conference Proceedings  |  2022  |  RADIOTHERAPY AND ONCOLOGY

Stereotactic Radiotherapy and Short-course Pembrolizumab for Oligometastatic Renal Cell Carcinoma-The RAPPORT Trial

Shankar Siva, Mathias Bressel, Simon T Wood, Mark G Shaw, Sherene Loi, Shahneen K Sandhu, Ben Tran, Arun A Azad, Jeremy H Lewin, Katharine E Cuff, Howard Y Liu, Daniel Moon, Jeremy Goad, Lih-Ming Wong, Michael LimJoon, Jennifer Mooi, Sarat Chander, Declan G Murphy, Nathan Lawrentschuk, David Pryor

Journal article  |  2022  |  EUROPEAN UROLOGY

BACKGROUND: Stereotactic ablative body radiotherapy (SABR) is an option for oligometastatic clear cell renal cell carcinoma (ccRCC..

Stereotactic radiotherapy and pembrolizumab for oligometastatic renal tumors: The RAPPORT trial.

Shankar Siva, Mathias Bressel, Simon Wood, Mark Shaw, Sherene Loi, Shahneen Kaur Sandhu, Ben Tran, Arun Azad, Jeremy Howard Lewin, Katharine Cuff, Nitika Neha, Duncan Colyer, Paul J Neeson, Howard Liu, Sarat Chander, Daniel Moon, Jeremy Goad, Declan G Murphy, Nathan Lawrentschuk, David Pryor

Conference Proceedings  |  2021  |  JOURNAL OF CLINICAL ONCOLOGY

277 Background: Pembrolizumab monotherapy, whilst not standard of care, has demonstrated efficacy in clear cell renal cell carcin..

Results of phase II trial of intensified neoadjuvant treatment with interdigitating radiotherapy and chemotherapy with oxaliplatin, 5-fluorouracil and folinic acid in patients with locally advanced rectal cancer (PROARCT trial)

Sweet Ping Ng, Julie Chu, Sarat Chander, Mathias Bressel, Joseph McKendrick, Rachel Wong, Malcolm Steel, William K Murray, Trevor Leong, Alexander Heriot, Michael Michael, Samuel Y Ngan

Journal article  |  2021  |  RADIOTHERAPY AND ONCOLOGY

BACKGROUND AND PURPOSE: The chemotherapy exposure during chemoradiotherapy for rectal cancer is adequate for radiosensitization bu..

Safety, Efficacy, and Patterns of Failure After Single-Fraction Stereotactic Body Radiation Therapy (SBRT) for Oligometastases

Paolo Sogono, Mathias Bressel, Steven David, Mark Shaw, Sarat Chander, Julie Chu, Nikki Plumridge, Keelan Byrne, Nicholas Hardcastle, Tomas Kron, Greg Wheeler, Gerard G Hanna, Michael MacManus, David Ball, Shankar Siva

Journal article  |  2021  |  INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

PURPOSE: Fewer attendances for radiation therapy results in increased efficiency and less foot traffic within a radiation therapy ..

A phase I/II study of stereotactic radiotherapy and pembrolizumab for oligometastatic renal tumours (RAPPORT): Clinical trial protocol

David Pryor, Mathias Bressel, Nathan Lawrentschuk, Ben Tran, Jennifer Mooi, Jeremy Lewin, Arun Azad, Duncan Colyer, Nitika Neha, Mark Shaw, Sarat Chander, Paul Neeson, Daniel Moon, Katharine Cuff, Simon Wood, Declan G Murphy, Shahneen Sandhu, Sherene Loi, Shankar Siva

Journal article  |  2021  |  CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS

BACKGROUND: The management of oligometastatic clear cell renal cell carcinoma (ccRCC) varies widely, ranging from observation to r..